Treatment duration and long-term outcomes with daratumumab in transplant-ineligible newly diagnosed multiple myeloma from the phase 3 MAIA study Meeting Abstract
| Authors: | Moreau, P.; Facon, T.; Usmani, S.; Kumar, S.; Plesner, T.; Goldschmidt, H.; Orlowski, R.; Perrot, A.; Chari, A.; Cook, G.; Pei, H.; Van Rampelbergh, R.; Bartlett, J. B.; Uhlar, C.; Carson, R.; Bahlis, N. |
| Abstract Title: | Treatment duration and long-term outcomes with daratumumab in transplant-ineligible newly diagnosed multiple myeloma from the phase 3 MAIA study |
| Meeting Title: | 19th International Myeloma Society Annual Meeting (IMS) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. |
| Meeting Dates: | 2022 Aug 25-27 |
| Meeting Location: | Los Angeles, CA |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-08-01 |
| Start Page: | S23 |
| End Page: | S24 |
| Language: | English |
| ACCESSION: | WOS:000895909200040 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(22)00312-3 |
| Notes: | Meeting Abstract: OAB-039 -- Source: Wos |
